Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Linna Wang | Researchclopedia

Back to researchers

Linna Wang

53

Works

2,899

Citations

19

h-index

25

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Hepatocellular Carcinoma Treatment and Prognosis Cancer Research and Treatments

Affiliations

Hebei Medical University2014–2023

Beijing Institute of Technology2017–2017

Central South University2008–2008

Sun Yat-sen University2023–2023

China Pharmaceutical University2013–2018

Top Works

Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial

Shukui Qin,Zhenggang Ren,et al.

2020632 citations

Gastric Cancer Management and Outcomes

Gastrointestinal Tumor Research and Treatment

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study

Shukui Qin,Stephen L. Chan,et al.

2023619 citations

Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial

Feng Wang,Shukui Qin,et al.

2020135 citations

Camrelizumab Combined with Chemotherapy Followed by Camrelizumab plus Apatinib as First-line Therapy for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Zhi Peng,Jia Wei,et al.

2021115 citations

Calcium-dependent activation of CPK12 facilitates its cytoplasm-to-nucleus translocation to potentiate plant hypoxia sensing by phosphorylating ERF-VII transcription factors

Biao Fan,Ke Liao,et al.

202379 citations

Bifunctional anti-PD-L1/TGF-βRII agent SHR-1701 in advanced solid tumors: a dose-escalation, dose-expansion, and clinical-expansion phase 1 trial

Dan Liu,Jun Zhou,et al.

202275 citations

Camrelizumab in combination with apatinib in second-line or above therapy for advanced primary liver cancer: cohort A report in a multicenter phase Ib/II trial

Kuimin Mei,Shukui Qin,et al.

202170 citations

A phase II study of anti–PD-1 antibody camrelizumab plus FOLFOX4 or GEMOX systemic chemotherapy as first-line therapy for advanced hepatocellular carcinoma or biliary tract cancer.

Shukui Qin,Zhendong Chen,et al.

201969 citations

The edaravone and 3-n-butylphthalide ring-opening derivative 10b effectively attenuates cerebral ischemia injury in rats

Kai Hua,Xiao Sheng,et al.

201558 citations